CPX-351 TREATMENT IN SECONDARY ACUTE MYELOID LEUKEMIA (SAML): THE REAL LIFE EXPERIENCE FROM THE "ITALIAN TRIVENETO REGISTRY"

被引：0

作者：

Fili, C. ^{[1
]}

Candoni, A. ^{[1
]}

Mauro, E. ^{[2
]}

Scattolin, A. M. ^{[3
]}

Leoncin, M. ^{[3
]}

Gurrieri, C. ^{[4
]}

Nadali, G. ^{[5
]}

Mosna, F. ^{[6
]}

Michieli, M. G. ^{[7
]}

Lico, A. ^{[8
]}

Lazzarotto, D. ^{[1
]}

Zannier, M. E. ^{[1
]}

Simeone, E. ^{[1
]}

Facchin, G. ^{[1
]}

Battaglia, G. ^{[1
]}

Gherlinzoni, F. ^{[2
]}

Bassan, R. ^{[3
]}

Semenzato, G. ^{[4
]}

Fanin, R. ^{[1
]}

机构：

[1] Azienda Sanitaria Friuli Cent, Ctr Trapianti & Terapie Cellulari, SOC Clin Ematol, Udine, Italy

[2] Osped Ca Foncello, Azienda ULSS9, Struttura Complessa Ematol, Treviso, Italy

[3] Osped Angelo, Azienda ULSS3 Serenissima, UO Ematol, Venice, Italy

[4] Azienda Osped Padova, UO Ematol & Immunol Clin, Padua, Italy

[5] Azienda Osped Univ Integrata, Policlin GB Rossi, UOC Ematol, Verona, Italy

[6] Azienda Sanitaria Alto Adige, Comprensorio Sanitario Bolzano, Ematol & CTMO, Bolzano, Italy

[7] Ctr Riferimento Oncol CRO, SOSD Terapia Cellulare & Chemioterapia Alte Dosi, Aviano, Italy

[8] Osped S Bortolo, Unita Operat Ematol, Vicenza, Italy

来源：

HAEMATOLOGICA | 2021年 / 106卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

D048

引用

页码：128 / 129

页数：2

共 50 条

[1] Efficacy and Safety Profile of CPX-351 in Secondary Acute Myeloid Leukemia (sAML): A Systematic Review
Ibrahim, Ahmed
Yousaf, Muhammad Abdullah
Ikram, Mariam
Khalid, Huma
Anum
Safdar, Omar A.
Anwer, Zain
Faraz, Fatima
Rehman, Mohammad
Saad, Muhammad
BLOOD, 2023, 142
[2] CPX-351: changing the landscape of treatment for patients with secondary acute myeloid leukemia
Talati, Chetasi
Lancet, Jeffrey E.
FUTURE ONCOLOGY, 2018, 14 (12) : 1147 - 1154
[3] Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia
Christina Rautenberg
Friedrich Stölzel
Christoph Röllig
Matthias Stelljes
Verena Gaidzik
Michael Lauseker
Oliver Kriege
Mareike Verbeek
Julia Marie Unglaub
Felicitas Thol
Stefan W. Krause
Mathias Hänel
Charlotte Neuerburg
Vladan Vucinic
Christian-Friedrich Jehn
Julia Severmann
Maxi Wass
Lars Fransecky
Jens Chemnitz
Udo Holtick
Kerstin Schäfer-Eckart
Josephine Schröder
Sabrina Kraus
William Krüger
Ulrich Kaiser
Sebastian Scholl
Kathrin Koch
Lea Henning
Guido Kobbe
Rainer Haas
Nael Alakel
Maximilian-Alexander Röhnert
Katja Sockel
Maher Hanoun
Uwe Platzbecker
Tobias A. W. Holderried
Anke Morgner
Michael Heuser
Tim Sauer
Katharina S. Götze
Eva Wagner-Drouet
Konstanze Döhner
Hartmut Döhner
Christoph Schliemann
Johannes Schetelig
Martin Bornhäuser
Ulrich Germing
Thomas Schroeder
Jan Moritz Middeke
Blood Cancer Journal, 11
[4] Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia
Rautenberg, Christina
Stoelzel, Friedrich
Roellig, Christoph
Stelljes, Matthias
Gaidzik, Verena
Lauseker, Michael
Kriege, Oliver
Verbeek, Mareike
Unglaub, Julia Marie
Thol, Felicitas
Krause, Stefan W.
Haenel, Mathias
Neuerburg, Charlotte
Vucinic, Vladan
Jehn, Christian-Friedrich
Severmann, Julia
Wass, Maxi
Fransecky, Lars
Chemnitz, Jens
Holtick, Udo
Schaefer-Eckart, Kerstin
Schroeder, Josephine
Kraus, Sabrina
Krueger, William
Kaiser, Ulrich
Scholl, Sebastian
Koch, Kathrin
Henning, Lea
Kobbe, Guido
Haas, Rainer
Alakel, Nael
Roehnert, Maximilian-Alexander
Sockel, Katja
Hanoun, Maher
Platzbecker, Uwe
Holderried, Tobias A. W.
Morgner, Anke
Heuser, Michael
Sauer, Tim
Goetze, Katharina S.
Wagner-Drouet, Eva
Doehner, Konstanze
Doehner, Hartmut
Schliemann, Christoph
Schetelig, Johannes
Bornhaeuser, Martin
Germing, Ulrich
Schroeder, Thomas
Middeke, Jan Moritz
BLOOD CANCER JOURNAL, 2021, 11 (10)
[5] Real-world experience with CPX-351 in high-risk acute myeloid leukemia
Lemoli, Roberto M.
Montesinos, Pau
Jain, Akriti
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2023, 185
[6] Liposomal cytarabine and daunorubicin (CPX-351) for treatment of acute myeloid leukemia
Ronson, Aaron
Tvito, Ariella
Rowe, Jacob M.
EXPERT OPINION ON ORPHAN DRUGS, 2017, 5 (04): : 369 - 374
[7] Real World Outcomes of CPX-351 Compared to Traditional Chemotherapy with Cytarabine Consolidation for Treatment of Secondary Acute Myeloid Leukemia
Granger, Katelynn
Gaffney, Kelly J.
Smith, Deidra
Weeda, Erin
Baratam, Praneeth
Green, Kimberly Michelle
Coltoff, Alexander
Davis, James A.
BLOOD, 2023, 142
[8] DECITABINE IN PATIENTS WITH NEWLY DIAGNOSED AND RELAPSED ACUTE MYELOID LEUKEMIA: THE REAL LIFE EXPERIENCE FROM THE "ITALIAN TRIVENETO REGISTRY"
Fili, C.
Candoni, A.
Imbergamo, S.
Festini, G.
Nadali, G.
Di Bona, E.
Ermacora, A.
Gottardi, M.
Michieli, M. G.
Caizzi, M.
Facchinelli, D.
Ciancia, R.
Lazzarotto, D.
Zannier, M. E.
Gherlinzoni, F.
Semenzato, G.
Fanin, R.
HAEMATOLOGICA, 2017, 102 : 8 - 9
[9] Real-World Experience of CPX-351 As First-Line Treatment in 188 Patients with Acute Myeloid Leukemia
Rautenberg, Christina
Stoelzel, Friedrich
Roellig, Christoph
Stelljes, Matthias
Gaidzik, Verena
Lauseker, Michael
Kriege, Oliver
Verbee, Mareike
Unglaub, Julia Marie
Thol, Felicitas
Krause, Stefan W.
Haenel, Mathias
Neuerburg, Charlotte
Vucinic, Vladan
Jehn, Christian-Friedrich
Severmann, Julia
Wass, Maxi
Fransecky, Lars
Chemnitz, Jens
Holtick, Udo
Schaefer-Eckart, Kerstin
Schroeder, Josephine
Kraus, Sabrina
Krueger, William
Kaiser, Ulrich
Scholl, Sebastian
Koch, Kathrin
Henning, Lea
Kobbe, Guido
Haas, Rainer
Alakel, Nael
Roehnert, Maximilian-Alexander
Sockel, Katja
Hanoun, Maher
Platzbecker, Uwe
Holderried, Tobias A. W.
Morgner, Anke
Heuser, Michael
Sauer, Tim
Goetze, Katharina S.
Wagner-Drouet, Eva
Doehne, Konstanze
Doehner, Hartmut
Schliemann, Christoph
Schetelig, Johannes
Bornhaeuser, Martin
Germing, Ulrich
Schroeder, Thomas
Middeke, Jan Moritz
BLOOD, 2021, 138
[10] CPX-351 for the Treatment of High-Risk Patients with Acute Myeloid Leukemia
Assi, Rita
Kantarjian, Hagop M.
Verstovsek, Srdan
Garcia-Manero, Guillermo
Konopleva, Marina
Ravandi, Farhad
DiNardo, Courtney D.
Kadia, Tapan M.
Daver, Naval
Jabbour, Elias J.
Gborogen, Rosilyn A.
Chamoun, Kamal
Wierda, William G.
Borthakur, Gautam
Cortes, Jorge E.
BLOOD, 2016, 128 (22)

← 1 2 3 4 5 →